Aficamten Advancing for Cardiomyopathy After SEQUOIA-HCM : vimarsana.com

The investigational oral drug leads to "clinically meaningful" improvements in obstructive hypertrophic cardiomyopathy, a pivotal trial shows.

Related Keywords

Lisbon , Lisboa , Portugal , United Kingdom , Burlington , Massachusetts , United States , Mayo Clinic In Rochester , Minnesota , Stever Ommen , Perrym Elliott , Martins Maron , , Department Of Medicine , University Of Glasgow , Metabolic Health , School Of Cardiovascular , Hypertrophic Cardiomyopathy Center At Lahey Hospital , Hypertrophic Cardiomyopathy Center , Lahey Hospital , Medical Center , Heart Failure Association , European Society , New England Journal , Cardiovascular Science , University College London , Mayo Clinic , Kansas City Cardiomyopathy Questionnaire , Clinical Summary Score ,